关注
Esma Isenovic
Esma Isenovic
Institute Vinca, University of Belgrade
在 vin.bg.ac.rs 的电子邮件经过验证
标题
引用次数
引用次数
年份
Leptin and obesity: role and clinical implication
M Obradovic, E Sudar-Milovanovic, S Soskic, M Essack, S Arya, ...
Frontiers in endocrinology 12, 585887, 2021
6322021
Apoptosis and acute brain ischemia in ischemic stroke
D Radak, N Katsiki, I Resanovic, A Jovanovic, E Sudar-Milovanovic, ...
Current vascular pharmacology 15 (2), 115-122, 2017
4132017
Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases
A Trpkovic, I Resanovic, J Stanimirovic, D Radak, SA Mousa, ...
Critical reviews in clinical laboratory sciences 52 (2), 70-85, 2015
3792015
Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway
L Vucicevic, M Misirkic, J Kristina, U Vilimanovich, E Sudar, E Isenovic, ...
Autophagy 7 (1), 40-50, 2011
2712011
Link between metabolic syndrome and insulin resistance
Z Gluvic, B Zaric, I Resanovic, M Obradovic, A Mitrovic, D Radak, ...
Current vascular pharmacology 15 (1), 30-39, 2017
2412017
Homocysteine and hyperhomocysteinaemia
BL Zaric, M Obradovic, V Bajic, MA Haidara, M Jovanovic, ER Isenovic
Current medicinal chemistry 26 (16), 2948-2961, 2019
2342019
Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure
SS Soskić, BD Dobutović, EM Sudar, MM Obradović, DM Nikolić, ...
The open cardiovascular medicine journal 5, 153, 2011
2082011
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches
D Nikolic, N Katsiki, G Montalto, ER Isenovic, DP Mikhailidis, M Rizzo
Nutrients 5 (3), 928-948, 2013
1972013
Interleukin-1β regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes
MC LaPointe, E Isenović
Hypertension 33 (1), 276-282, 1999
1861999
Heart disease in diabetic patients
MC Blendea, SI McFarlane, ER Isenovic, G Gick, JR Sowers
Current Diabetes Reports 3 (3), 223-229, 2003
1362003
Link between oxidative stress and acute brain ischemia
D Radak, I Resanovic, ER Isenovic
Angiology 65 (8), 667-676, 2014
1322014
Glutathione “redox homeostasis” and its relation to cardiovascular disease
VP Bajic, C Van Neste, M Obradovic, S Zafirovic, D Radak, VB Bajic, ...
Oxidative medicine and cellular longevity 2019 (1), 5028181, 2019
1272019
Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome
N Abate, H S Sallam, M Rizzo, D Nikolic, M Obradovic, P Bjelogrlic, ...
Current pharmaceutical design 20 (31), 4961-4969, 2014
1262014
Thrombin and vascular inflammation
M Popović, K Smiljanić, B Dobutović, T Syrovets, T Simmet, ER Isenović
Molecular and cellular biochemistry 359, 301-313, 2012
1242012
Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study
M Rizzo, N Abate, M Chandalia, AA Rizvi, RV Giglio, D Nikolic, ...
The journal of clinical endocrinology & metabolism 100 (2), 603-606, 2015
1152015
Human cytomegalovirus infection and atherothrombosis
M Popović, K Smiljanić, B Dobutović, T Syrovets, T Simmet, ER Isenović
Journal of Thrombosis and Thrombolysis 33, 160-172, 2012
1072012
Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with α-lipoic acid through phosphatidylinositol 3-kinase/Akt-dependent mechanism
MS Bitar, AK Ayed, SM Abdel-Halim, ER Isenovic, F Al-Mulla
Life Sciences 86 (23-24), 844-853, 2010
922010
Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile
E Stokić, A Kupusinac, D Tomić-Naglić, BK Zavišić, M Mitrović, ...
Angiology 66 (3), 237-243, 2015
842015
PCSK9 inhibition-a novel mechanism to treat lipid disorders?
M Banach, M Rizzo, M Obradovic, G Montalto, J Rysz, D P Mikhailidis, ...
Current pharmaceutical design 19 (21), 3869-3877, 2013
782013
AMP-activated protein kinase-dependent and-independent mechanisms underlying in vitro antiglioma action of compound C
L Vucicevic, M Misirkic, K Janjetovic, L Harhaji-Trajkovic, M Prica, ...
Biochemical pharmacology 77 (11), 1684-1693, 2009
752009
系统目前无法执行此操作,请稍后再试。
文章 1–20